Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 12.2.2018 | EN | Official Journal of the European Union | C 52/43 |

---

Action brought on 29 December 2017 — DRH Licensing & Managing v EUIPO — Merck (Flexagil)

(Case T-831/17)

(2018/C 052/57)

Language in which the application was lodged: German

Parties

Applicant: DRH Licensing & Managing AG (Zürich, Switzerland) (represented by: S. Salomonowitz, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Merck KGaA (Darmstadt, Germany)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: EU figurative mark including the word element ‘Flexagil’ — EU trade mark No 7 301 237

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 17 October 2017 in Case R 2043/2016-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul decision R 2043/2016-4 of the Board of Appeal of 17 October 2017 in its entirety; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs incurred by the applicant in these proceedings and in the appeal proceedings relating to Case R 2043/2016. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 58(1)(a) of Regulation 2017/1001; |

|  |  |
| --- | --- |
| — | Infringement of Article 18 of Regulation 2017/1001. |

---

[Top](#document1)